Tango Therapeutics, Inc. (TNGX)
11.50
-0.03
(-0.26%)
USD |
NASDAQ |
Mar 03, 16:00
11.45
-0.05
(-0.43%)
After-Hours: 20:00
Tango Therapeutics Research and Development Expense (Annual) : 143.92M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| AbbVie, Inc. | 8.249B |
| Teleflex, Inc. | 144.78M |
| Recursion Pharmaceuticals, Inc. | 425.27M |
| Amicus Therapeutics, Inc. | 135.84M |
| EyePoint Plc | 132.93M |